- Home
- CADL vs VACH Comparison
CADL vs VACH Comparison
Compare CADL & VACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- VACH
- Stock Information
- Founded
- CADL 1999
- VACH 2023
- Country
- CADL United States
- VACH United States
- Employees
- CADL N/A
- VACH N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- VACH
- Sector
- CADL Health Care
- VACH
- Exchange
- CADL Nasdaq
- VACH NYSE
- Market Cap
- CADL 306.4M
- VACH 321.3M
- IPO Year
- CADL 2021
- VACH 2024
- Fundamental
- Price
- CADL $8.06
- VACH $10.20
- Analyst Decision
- CADL Strong Buy
- VACH
- Analyst Count
- CADL 4
- VACH 0
- Target Price
- CADL $21.00
- VACH N/A
- AVG Volume (30 Days)
- CADL 1.2M
- VACH 837.0
- Earning Date
- CADL 03-13-2025
- VACH 01-01-0001
- Dividend Yield
- CADL N/A
- VACH N/A
- EPS Growth
- CADL N/A
- VACH N/A
- EPS
- CADL N/A
- VACH N/A
- Revenue
- CADL N/A
- VACH N/A
- Revenue This Year
- CADL N/A
- VACH N/A
- Revenue Next Year
- CADL N/A
- VACH N/A
- P/E Ratio
- CADL N/A
- VACH N/A
- Revenue Growth
- CADL N/A
- VACH N/A
- 52 Week Low
- CADL $1.40
- VACH $9.97
- 52 Week High
- CADL $14.60
- VACH $10.25
- Technical
- Relative Strength Index (RSI)
- CADL 45.77
- VACH N/A
- Support Level
- CADL $8.33
- VACH N/A
- Resistance Level
- CADL $9.08
- VACH N/A
- Average True Range (ATR)
- CADL 0.59
- VACH 0.00
- MACD
- CADL -0.04
- VACH 0.00
- Stochastic Oscillator
- CADL 42.70
- VACH 0.00
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About VACH VOYAGER ACQUISITION CORP.
Voyager Acquisition Corp is a blank check company.